MicroPhage's technology allows existing detection platforms to now work at higher rates of sensitivity and specificity in a wide array of clinical matrices. One example of this is direct detection of bacteria from blood (either whole blood or blood culture). This page briefly explains this attribute.

Phage Amplification-Enabling Immunoassays for Direct Detection of Bacteria

This section is currently under development. Please check back soon for more information.

MicroPhage is currently developing its technology for direct detection of bacteri in blood and blood cultures and does not have an market-ready product available on the market. This explanation of the technology is meant only as reference, and should not be construed as product performance.